Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
October-2015 Volume 10 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2015 Volume 10 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid

  • Authors:
    • Alejandro D. Soriano‑Hernandez
    • Daniela Madrigal‑Pérez
    • Hector R. Galvan‑Salazar
    • Margarita L. Martinez‑Fierro
    • Laura L. Valdez‑Velazquez
    • Francisco Espinoza‑Gómez
    • Oscar F. Vazquez‑Vuelvas
    • Bertha A. Olmedo‑Buenrostro
    • Jose Guzman‑Esquivel
    • Iram P. Rodriguez‑Sanchez
    • Agustin Lara‑Esqueda
    • Daniel A. Montes‑Galindo
    • Ivan Delgado‑Enciso
  • View Affiliations / Copyright

    Affiliations: School of Medicine, University of Colima, Colima, Colima 28030, Mexico, Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autononous University of Zacatecas, Zacatecas, Zacatecas 98160, Mexico, School of Chemistry, University of Colima, Coquimatlán Colima 28400, Mexico, General Hospital of Zone No. 1, Mexican Institute of Social Security, Colima, Colima 28000, Mexico, Department of Genetics, School of Medicine, Nuevo Leon Autonomous University, Monterrey, Nuevo León 64460, Mexico, Cancerology State Institute, Colima State Health Services, Colima, Colima 28000, Mexico
  • Pages: 2574-2578
    |
    Published online on: August 7, 2015
       https://doi.org/10.3892/ol.2015.3580
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Uterine cervical cancer (UCC) is one of the main causes of cancer‑associated mortality in women. Inflammation has been identified as an important component of this neoplasia; in this context, anti‑inflammatory drugs represent possible prophylactic and/or therapeutic alternatives that require further investigation. Anti‑inflammatory drugs are common and each one may exhibit a different antineoplastic effect. As a result, the present study investigated different anti‑inflammatory models of UCC in vitro and in vivo. Celecoxib, sulindac, nimesulide, dexamethasone, meclofenamic acid, flufenamic acid and mefenamic acid were tested in UCC HeLa, VIPA, INBL and SiHa cell lines. The cytotoxicity of the drugs was evaluated in vitro. Celecoxib, sulindac, nimesulide, mefenamic acid and flufenamic acid presented with slight to moderate toxicity (10‑40% of cell death corresponding to 100 µM) in certain cell lines, while meclofenamic acid exhibited significant cytotoxicity in all essayed cell lines (50‑90% of cell death corresponding to 100 µM). The meclofenamic acid was tested in murine models (immunodeficient and immunocompetent) of UCC, which manifested a significant reduction in tumor growth and increased mouse survival. It was demonstrated that of the evaluated anti‑inflammatory drugs, meclofenamic acid was the most cytotoxic, with a significant antitumor effect in murine models. Subsequent studies are necessary to evaluate the clinical utility of this drug.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Howley P and Lowy D: Papillomaviruses and their replicationFields Virology. Knipe DM and Howley PM: Lippincott Williams & Wilkins; Philadelphia, PA: pp. 2197–2229. 2001

2 

Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI

3 

Hold GL and El-omar EM: Genetic aspects of inflammation and cancer. Biochem J. 410:225–235. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Vane J: Towards a better aspirin. Nature. 367:215–216. 1994. View Article : Google Scholar : PubMed/NCBI

5 

FitzGerald GA and Patrono C: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 345:433–442. 2001. View Article : Google Scholar : PubMed/NCBI

6 

Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC and Seibert K: Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem. J. 305:479–484. 1995. View Article : Google Scholar : PubMed/NCBI

7 

Gruber BM, Bubko I, KrzysztonRussjan J and Anuszewska EL: Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms. Med Sci Monit. 16:BR45–BR51. 2010.PubMed/NCBI

8 

Crum C, Muovo G and Lee K: The cervixSternberg S: Diagnostic Surgical Pathology. 3rd. Lippincott Williams & Wilkins; Philadelphia, PA: pp. 2155–2202. 1999

9 

Bauman DR, Steckelbroeck S and Penning TM: The roles of Aldo-Keto reductases in steroid hormone action. Drug News Perspect. 17:563–578. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Bauman DR, Rudnick SI, Szewczuk LM, et al: Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes. Mol Pharmacol. 67:60–68. 2005. View Article : Google Scholar : PubMed/NCBI

11 

Soriano-Hernández AD, Galvan-Salazar HR, Montes-Galindo DA, et al: Antitumor effect of meclofenamic acid on human androgen-independent prostate cancer: A preclinical evaluation. Int Urol Nephrol. 44:471–477. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Rahbari R, Sheahan T, Modes V, Collier P, Macfarlane C and Badge RM: A novel L1 retrotransposon marker for HeLa cell line identification. Biotechniques. 46:277–284. 2009.PubMed/NCBI

13 

Watson DM: The Virginian-Pilot: HeLa Cancer cells killed Henrietta Lacks - then made her immortal. http://hamptonroads.com/2010/05/cancer-cells-killed-henrietta-lacks-then-made-her-immortalAccessed. September 17–2014.

14 

Kim KM, Song JJ, An JY, Kwon YT and Lee YJ: Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression. J Biol Chem. 280:41047–41056. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Blaheta RA, Weich E, Marian D, BereiterHahn J, Jones J, Jonas D, Michaelis M, Doerr HW and Cinatl J Jr: Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells, and extracellular matrix. Neoplasia. 8:807–816. 2006. View Article : Google Scholar : PubMed/NCBI

16 

Kim SH, Song SH, Kim SG, Chun KS, Lim SY, Na HK, Kim JW, Surh YJ, Bang YJ and Song YS: Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target. J Cancer Res Clin Oncol. 130:551–560. 2004. View Article : Google Scholar : PubMed/NCBI

17 

Al-Nasiry S, Geusens N, Hanssens M, Luyten C and Pijnenborg R: The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod. 22:1304–1309. 2007. View Article : Google Scholar : PubMed/NCBI

18 

Stephenson RA, Dinney CP, Gohji K, Ordonez NG, Killion JJ and Fidler IJ: Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst. 84:951–957. 1992. View Article : Google Scholar : PubMed/NCBI

19 

Koziol JA, Maxwell DA, Fukushima M, Colmerauer ME and Pilch YH: A distribution-free test for tumor-growth curve analyses with application to an animal tumor immunotherapy experiment. Biometrics. 37:383–390. 1981. View Article : Google Scholar : PubMed/NCBI

20 

SAGARPA: Technical specifications for the care and use of laboratory animals of the Mexican Official Standard (NOM-062-ZOO-1999). https://www.fmvz.unam.mx/fmvz/principal/archivos/062ZOO.PDF(In Spanish). Accessed. June 17–2015.

21 

Quann EJ, Khwaja F, Zavitz KH and Djakiew D: The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells. Cancer Res. 67:3254–3262. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Adachi M, Sakamoto H, Kawamura R, Wang W, Imai K and Shinomura Y: Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells. Histol Histopathol. 22:437–442. 2007.PubMed/NCBI

23 

Sakonlaya D, Tapanadechopone P, Poomkokruk A and Charoenvilaisiri S: Do NSAID's Inhibit growth of precancerous cervical cells in vitro? J Med Assoc Thai. 95:(Suppl 1). S65–S73. 2012.PubMed/NCBI

24 

Wang AH, Tian XY, Yu JJ, Mi JQ, Liu H and Wang RF: Celecoxib radiosensitizes the human cervical cancer HeLa cell line via a mechanism dependent on reduced cyclo-oxygenase-2 and vascular endothelial growth factor C expression. J Int Med Res. 40:56–66. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Small W and Greven K: Efficacy and Patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys. 69:111–117. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Soriano‑Hernandez AD, Madrigal‑Pérez D, Galvan‑Salazar HR, Martinez‑Fierro ML, Valdez‑Velazquez LL, Espinoza‑Gómez F, Vazquez‑Vuelvas OF, Olmedo‑Buenrostro BA, Guzman‑Esquivel J, Rodriguez‑Sanchez IP, Rodriguez‑Sanchez IP, et al: Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid. Oncol Lett 10: 2574-2578, 2015.
APA
Soriano‑Hernandez, A.D., Madrigal‑Pérez, D., Galvan‑Salazar, H.R., Martinez‑Fierro, M.L., Valdez‑Velazquez, L.L., Espinoza‑Gómez, F. ... Delgado‑Enciso, I. (2015). Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid. Oncology Letters, 10, 2574-2578. https://doi.org/10.3892/ol.2015.3580
MLA
Soriano‑Hernandez, A. D., Madrigal‑Pérez, D., Galvan‑Salazar, H. R., Martinez‑Fierro, M. L., Valdez‑Velazquez, L. L., Espinoza‑Gómez, F., Vazquez‑Vuelvas, O. F., Olmedo‑Buenrostro, B. A., Guzman‑Esquivel, J., Rodriguez‑Sanchez, I. P., Lara‑Esqueda, A., Montes‑Galindo, D. A., Delgado‑Enciso, I."Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid". Oncology Letters 10.4 (2015): 2574-2578.
Chicago
Soriano‑Hernandez, A. D., Madrigal‑Pérez, D., Galvan‑Salazar, H. R., Martinez‑Fierro, M. L., Valdez‑Velazquez, L. L., Espinoza‑Gómez, F., Vazquez‑Vuelvas, O. F., Olmedo‑Buenrostro, B. A., Guzman‑Esquivel, J., Rodriguez‑Sanchez, I. P., Lara‑Esqueda, A., Montes‑Galindo, D. A., Delgado‑Enciso, I."Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid". Oncology Letters 10, no. 4 (2015): 2574-2578. https://doi.org/10.3892/ol.2015.3580
Copy and paste a formatted citation
x
Spandidos Publications style
Soriano‑Hernandez AD, Madrigal‑Pérez D, Galvan‑Salazar HR, Martinez‑Fierro ML, Valdez‑Velazquez LL, Espinoza‑Gómez F, Vazquez‑Vuelvas OF, Olmedo‑Buenrostro BA, Guzman‑Esquivel J, Rodriguez‑Sanchez IP, Rodriguez‑Sanchez IP, et al: Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid. Oncol Lett 10: 2574-2578, 2015.
APA
Soriano‑Hernandez, A.D., Madrigal‑Pérez, D., Galvan‑Salazar, H.R., Martinez‑Fierro, M.L., Valdez‑Velazquez, L.L., Espinoza‑Gómez, F. ... Delgado‑Enciso, I. (2015). Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid. Oncology Letters, 10, 2574-2578. https://doi.org/10.3892/ol.2015.3580
MLA
Soriano‑Hernandez, A. D., Madrigal‑Pérez, D., Galvan‑Salazar, H. R., Martinez‑Fierro, M. L., Valdez‑Velazquez, L. L., Espinoza‑Gómez, F., Vazquez‑Vuelvas, O. F., Olmedo‑Buenrostro, B. A., Guzman‑Esquivel, J., Rodriguez‑Sanchez, I. P., Lara‑Esqueda, A., Montes‑Galindo, D. A., Delgado‑Enciso, I."Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid". Oncology Letters 10.4 (2015): 2574-2578.
Chicago
Soriano‑Hernandez, A. D., Madrigal‑Pérez, D., Galvan‑Salazar, H. R., Martinez‑Fierro, M. L., Valdez‑Velazquez, L. L., Espinoza‑Gómez, F., Vazquez‑Vuelvas, O. F., Olmedo‑Buenrostro, B. A., Guzman‑Esquivel, J., Rodriguez‑Sanchez, I. P., Lara‑Esqueda, A., Montes‑Galindo, D. A., Delgado‑Enciso, I."Anti‑inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid". Oncology Letters 10, no. 4 (2015): 2574-2578. https://doi.org/10.3892/ol.2015.3580
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team